Indonesia and its state-owned PT Kimia Farma are moving to make the nation independent of imported versions of HIV/AIDS drugs.

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Venture Funding column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced October through November 2013.

Univfy Inc. has developed evidence-based, personalized prediction models of in vitro fertilization treatment success for fertility patients and their health care providers, as a support tool to help increase the success of IVF, decrease dropout rates, and better assess the risks of the procedure.

Ovuline Inc. is using powerful algorithms based upon the input of more than two million fertility-related data points to help women conceive faster and have a healthy pregnancy. Its web- and mobile app-based product, Smart Fertility, takes into account personal information entered by its users to help predict when ovulation will occur and offer advice about what to do every day to maximize fertility.